Amandine HURBIN
CRHC Inserm
My research focuses on characterizing mechanisms of resistance to targeted therapies in cancer, with a particular interest in the role of the tumor microenvironment and interactions between growth factor receptors and integrins. My main goal is to identify prognostic biomarkers and potential targets for the development of more precise diagnostics, innovative targeted therapies and nanomedicines capable of reaching tumors, their microenvironment and metastases.